ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

702 hedge funds and large institutions have $22.6B invested in Alexion Pharmaceuticals Inc in 2020 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 261 increasing their positions, 262 reducing their positions, and 70 closing their positions.

Holders
702
Holders Change
+2
Holders Change %
+0.29%
% of All Funds
14.2%
Holding in Top 10
18
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-14.29%
% of All Funds
0.36%
New
75
Increased
261
Reduced
262
Closed
70
Calls
$275M
Puts
$315M
Net Calls
-$40.8M
Net Calls Change
+$31.5M

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.27B
2
Janus Henderson Group
2
Janus Henderson Group
United Kingdom
$177M
3
Man Group
3
Man Group
United Kingdom
$156M
4
AL
4
AJO LP
Pennsylvania
$101M
5
Nomura Holdings
5
Nomura Holdings
Japan
$76.5M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$357M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.12B
3
Ameriprise
3
Ameriprise
Minnesota
$584M
4
HM
4
HealthCor Management
New York
$0
5
DnB Asset Management
5
DnB Asset Management
Norway
$11.5M
Name Market Value Shares Shares
Change 		Shares
Change %
CAC
776
Cowen and Company
New York
– – – –
NFG
777
Next Financial Group
Texas
$0 4 +4 New
CFB
778
Cullen/Frost Bankers
Texas
$0 4 +4 New
28 29 30 31
32